Chennai, May 18th 2017:TAKE Solutions Ltd. [BSE: 532890 | NSE: TAKE], a globally recognized knowledge and innovation intensive Life Sciences expert, today announced its financial results for Q4 and year ended FY17. The company reported FY17 revenues of INR 13,446 Mn, a 30.5% growth over the previous year.

Key highlights:

  • The company continued along its transformational scale-up journey, taking significant strides towards emerging as a 500 Mn USD enterprise by the year 2021.
  • The company added 9 new Life Sciences customers during Q4 FY17
  • The company announced the appointment of Mr. Krishnan Rajagopal as Chief Growth Officer of its Life Sciences business Navitas. Mr. Rajagopalan comes with over two decades of experience in Life Sciences - domain and technology consulting, advisory services and P&L management. He has been instrumental in building Tier 1 Life Sciences consulting and functional business process operations services for companies such as Infosys, and Cognizant Life Sciences, USA.
  • The company received an award for the 'Most Effective Campaign' at the prestigious Asian Customer Engagement Forum Awards

Srinivasan H.R., Vice-Chairman and Managing Director, TAKE Solutions said, 'Since embarking on our 5-year transformational scale-up journey, many developments have taken place within our organization across our various global entities that are registering tremendously positive business impact. We are further aligning our operations to deliver truly transformative end-to-end solutions across process, technology and analytics to global Life Sciences clients. Our consistently strong performance this year stands testimony to our progression along the track of accelerated growth.'

He further added, 'We continue to augment our already impressive and diverse Executive Leadership with Mr. Krishnan Rajagopalan coming on board as the Chief Growth Officer of our Life Sciences business, Navitas. His industry and leadership expertise will add tremendous value as we move forward towards our goal of being a larger, more impactful organization.'

About TAKE Solutions

TAKE Solutions is a globally recognized knowledge intensive player, delivering comprehensive and niche solutions for enterprises across diverse sectors for over 15 years, with key expertise in Life Sciences (LS). In this domain, TAKE offers IP-based software and extensive knowledge-based solutions to enable efficient clinical, regulatory, safety and content management. TAKE encompasses specialized lines of businesses under distinct brands such as Navitas - a technology-led Life Sciences services provider across Clinical, Regulatory and Safety, Ecron Acunova - a full-service CRO with Clinical & BA/BE capabilities, Intelent - an expert in Life Sciences Big Data and TAKE Innovations - an incubator to facilitate IP Creation.

TAKE's significant recognitions include a patent win from the United States Patent and Trademark Office (USPTO) for its 'Method for Optimizing Clinical Data Standardization', a 'Leader' certification in Drug Safety Services & Life Sciences R&D IT Outsourcing from IDC, recognition as the 'Dream Employer of the Year' at the World HRD Congress, the title of 'Most Admired Brand -IT' from the Asian Customer Engagement Forum and a Special Commendation for excellence in Corporate Governance from the Golden Peacock Awards. With its global headquarters in Chennai, India, TAKE has a proven track record of delivering world-class solutions to more than 400 customers worldwide, including 9 of the top 10 global Pharma companies. For more information, please visit www.takesolutions.com.

Contacts::
Samhita Suresh, TAKE Solutions, +91 44 66110700, samhita.suresh@takesolutions.com
Murugan G, 20:20 MSL, +91 9841278904, murugan.g@2020msl.com


Take Solutions Limited published this content on 18 May 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 18 May 2017 11:48:26 UTC.

Original documenthttp://www.takesolutions.com/take-solutions-reports-a-strong-growth-of-30-5-in-fy17-revenue

Public permalinkhttp://www.publicnow.com/view/A7570A1BDE7FFCF57165C2102EEDAA3AE425B4E0